Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Annales De Biologie Clinique|November 28, 2007
[Early detection of leptomeningeal metastasis in patients with metastatic breast carcinoma: validation of CA 15-3 measurement in cerebrospinal fluid]A-S Gauchez, E Pez, J Boutonnat, et al.
Bulletin Du Cancer|January 1, 1994
[Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin]D Moro, H Orfeuvre, H Nagy-Mignotte, et al.
European Cytokine Network|June 12, 2001
Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trialG Gravis, M Mousseau, J Y Douillard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumoursM Mousseau, C Chauvin, M F Nissou, et al.
Urologic Oncology|January 13, 2011
Rapidly recycled, intensive alternating chemotherapy in heavily pretreated progressive nonseminomatous germ cell tumors a feasibility studyS Culine, J P Droz, R Delva, et al.
Bulletin Du Cancer|April 16, 1998
[Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center]J P Vuillez, E Levrot, M Mousseau, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1990
[Association of 5-FU, CDDP and hypofractionated radiotherapy in recurrences of subtentorial astrocytomas and malignant gliomas in adults]M Bolla, P Vincent, A Benabid, et al.
American Journal of Clinical Oncology|April 25, 2000
Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer: an open-label multicenter phase II studyM Ychou, J Y Douillard, P Rougier, et al.
Bulletin Du Cancer|December 1, 1994
[Modulation of indications of adjuvant hormone therapy with tamoxifen in T1T2/N0N1 breast cancers. Preliminary results of a multicenter study with 695 cases]M Bolla, M Mousseau, P Winckel, et al.
Oncology|July 4, 2006
Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trialM Ducreux, O Bouche, J P Pignon, et al.
Pageof 6